Crossref journal-article
American Society for Microbiology
Antimicrobial Agents and Chemotherapy (235)
Abstract

ABSTRACT Twenty analogues of pentamidine, 7 primary metabolites of pentamidine, and 30 dicationic substituted bis-benzimidazoles were screened for their inhibitory and fungicidal activities against Candida albicans and Cryptococcus neoformans . A majority of the compounds had MICs at which 80% of the strains were inhibited (MIC 80 s) comparable to those of amphotericin B and fluconazole. Unlike fluconazole, many of these compounds were found to have potent fungicidal activity. The most potent compound against C. albicans had an MIC 80 of ≤0.09 μg/ml, and the most potent compound against C. neoformans had an MIC 80 of 0.19 μg/ml. Selected compounds were also found to be active against Aspergillus fumigatus , Fusarium solani , Candida species other than C. albicans , and fluconazole-resistant strains of C. albicans and C. neoformans . It is clear from the data presented here that further studies on the structure-activity relationships, mechanisms of action and toxicities, and in vivo efficacies of these compounds are warranted to determine their clinical potential.

Bibliography

Del Poeta, M., Schell, W. A., Dykstra, C. C., Jones, S., Tidwell, R. R., Czarny, A., Bajic, M., Bajic, M., Kumar, A., Boykin, D., & Perfect, J. R. (1998). Structure-In Vitro Activity Relationships of Pentamidine Analogues and Dication-Substituted Bis-Benzimidazoles as New Antifungal Agents. Antimicrobial Agents and Chemotherapy, 42(10), 2495–2502.

Authors 11
  1. Maurizio Del Poeta (first)
  2. Wiley A. Schell (additional)
  3. Christine C. Dykstra (additional)
  4. Susan Jones (additional)
  5. Richard R. Tidwell (additional)
  6. Agnieszka Czarny (additional)
  7. Miroslav Bajic (additional)
  8. Marina Bajic (additional)
  9. Arvind Kumar (additional)
  10. David Boykin (additional)
  11. John R. Perfect (additional)
References 41 Referenced 203
  1. 10.1515/HC.1995.1.4.225
  2. 10.1515/HC.1996.2.2.135
  3. 10.1093/jac/33.6.1229
  4. 10.1128/AAC.35.6.1099
  5. 10.1128/AAC.37.12.2668
  6. 10.1128/AAC.34.7.1381
  7. 10.1128/AAC.36.9.1825
  8. Berger B. J. Reddy V. V. Le S. T. Lombardy R. J. Hall J. E. Tidwell R. R. Hydroxylation of pentamidine by rat liver microsomes. J. Pharmacol. Exp. Ther. 256 1991 883 889 / J. Pharmacol. Exp. Ther. / Hydroxylation of pentamidine by rat liver microsomes. by Berger B. J. (1991)
  9. 10.1128/AAC.35.7.1520
  10. 10.1021/jm00006a009
  11. 10.1128/AAC.37.11.2449
  12. 10.1039/p19730002961
  13. 10.1002/jlac.19717490110
  14. 10.1002/jlac.19727600105
  15. 10.1021/jm00214a014
  16. 10.1128/AAC.38.9.1890
  17. 10.1021/jm00064a008
  18. 10.1016/0163-4453(91)91767-R
  19. 10.1128/AAC.42.3.666
  20. 10.1111/j.1550-7408.1998.tb05078.x
  21. 10.1128/AAC.34.6.1026
  22. Keku T. O. Seed J. R. Tidwell R. R. The in vitro HLK-60 cell-Trypanosoma brucei rhodesiense culture system: a rapid in vitro drug screen. Trop. Med. and Parasitol. 46 1995 258 262 / Trop. Med. and Parasitol. / The in vitro HLK-60 cell-Trypanosoma brucei rhodesiense culture system: a rapid in vitro drug screen. by Keku T. O. (1995)
  23. 10.7326/0003-4819-100-5-663
  24. 10.1016/0223-5234(96)83970-5
  25. 10.1128/AAC.35.9.1914
  26. 10.1128/AAC.38.5.1123
  27. McGinnis M. R. Susceptibility testing and bioassay procedure Susceptibility testing and bioassay procedure. 1980 431 Academic Press Inc. New York N.Y (10.1016/B978-0-12-482850-6.50010-1)
  28. 10.3891/acta.chem.scand.35b-0303
  29. Morikawa S. Synthesis of hydroxymethylfural and 2,5-furandicarboxaldehydes. Noguchi Kenkyusho Jiho 21 1979 25 33 / Noguchi Kenkyusho Jiho / Synthesis of hydroxymethylfural and 2,5-furandicarboxaldehydes. by Morikawa S. (1979)
  30. National Committee for Clinical Laboratory Standards Reference method for broth dilution susceptibility testing of yeasts. Document M27-T. 1995Tentative standard. National Committee for Clinical Laboratory Standards Wayne Pa.
  31. 10.1021/jo01351a093
  32. 10.1016/S0223-5234(99)80064-6
  33. 10.1128/jcm.32.1.59-64.1994
  34. 10.1128/AAC.34.12.2304
  35. Tidwell R. R. Bell C. A. Pentamidine and related compounds in the treatment of Pneumocystis carinii infection Pentamidine and related compounds in the treatment of Pneumocystis carinii Infection. Walzer P. D. 1993 561 583 Marcel Dekker Inc. New York N.Y
  36. 10.1021/jm00205a005
  37. 10.1111/j.1749-6632.1990.tb17862.x
  38. 10.1021/jm00166a026
  39. 10.1128/AAC.37.8.1713
  40. 10.7326/0003-4819-80-1-83
  41. 10.1093/jac/28.6.937
Dates
Type When
Created 6 years, 10 months ago (Oct. 8, 2018, 8:29 p.m.)
Deposited 3 years, 6 months ago (Feb. 21, 2022, 10:42 a.m.)
Indexed 26 minutes ago (Aug. 26, 2025, 11:38 p.m.)
Issued 26 years, 10 months ago (Oct. 1, 1998)
Published 26 years, 10 months ago (Oct. 1, 1998)
Published Print 26 years, 10 months ago (Oct. 1, 1998)
Funders 0

None

@article{Del_Poeta_1998, title={Structure-In Vitro Activity Relationships of Pentamidine Analogues and Dication-Substituted Bis-Benzimidazoles as New Antifungal Agents}, volume={42}, ISSN={1098-6596}, url={http://dx.doi.org/10.1128/aac.42.10.2495}, DOI={10.1128/aac.42.10.2495}, number={10}, journal={Antimicrobial Agents and Chemotherapy}, publisher={American Society for Microbiology}, author={Del Poeta, Maurizio and Schell, Wiley A. and Dykstra, Christine C. and Jones, Susan and Tidwell, Richard R. and Czarny, Agnieszka and Bajic, Miroslav and Bajic, Marina and Kumar, Arvind and Boykin, David and Perfect, John R.}, year={1998}, month=oct, pages={2495–2502} }